daraxonrasib

New Targeted Drug Nearly Doubles Survival Time For Pancreatic Cancer Patients In Major Trial

New Targeted Drug Nearly Doubles Survival Time For Pancreatic Cancer Patients In Major Trial

When patients sit in my office to discuss a metastatic pancreatic cancer diagnosis, their first question is almost always about their true life expectancy. For a long time, the survival statistics have been difficult to discuss. Our primary tool has been intravenous chemotherapy. It offers limited success and brings heavy toxicity. That is why the…

Permanent Disappearance of Pancreatic Cancer Achieved in New Triple-Drug Mouse Study
|

Permanent Disappearance of Pancreatic Cancer Achieved in New Triple-Drug Mouse Study

Pancreatic cancer remains one of medicine’s most stubborn enemies. It kills fast, hides well, and resists almost every drug we throw at it. But a team of researchers in Spain may have found a way to beat it at its own game. Scientists at the Spanish National Cancer Research Centre (CNIO) developed a triple-drug therapy…